Tadalafil Tablet, Film Coated
Product Images NDC 51655-487

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 51655-487). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (51655 487 52)

Label (51655 487 52)
NDC 51655-487-52 Rova 1120 is a pack of 30 tablets of Tadalafil, USP each containing 5mg of the drug. These tablets are meant for prescription-only use and should be stored at a temperature range of 15°C-30°C (59°F-86°F). The tablets should not be broken before consumption, and the entire dose must be taken. The lot number is 0000000000 which has been repackaged by Northwind Phamaceuticals from the manufacturer Accord Healthcare's product identified by GTIN 0035165487525 and S/N 000000000000000 with the expiry date and lot number both marked as 00/00/0000 and 0000000000 respectively. The package has to be kept in the original container out of children's reach.*
FDA Label Image

Figure (Tadalafil Figure1)

Figure (Tadalafil Figure1)
This is a chart showing the difference in blood pressure (mmHg) between Tadalafil and Placebo for both standing and supine positions. There is no further context or explanation provided.*
FDA Label Image

Figure (Tadalafil Figure2)

Figure (Tadalafil Figure2)
The text appears to represent a chart or table with measurements related to the use of Tadalafil and doxazosin medication. The first column may be time in hours after medication intake, and the second column may represent some form of measurement. The other characters and symbols seem to be irrelevant or unreadable, and therefore the nature or purpose of the measurements is not available.*
FDA Label Image

Figure (Tadalafil Figure3)

Figure (Tadalafil Figure3)
The text describes a table showing Systolic Blood Pressure (in mmHg) for different treatments (20 mg tadalafil or placebo) and different times after administration (-e- represents no data). The treatments are combined with 8 mg doxazosin and are administered at 8:00. One treatment is also administered at 20:00. Therefore, the table shows the effect of the treatments on blood pressure at different times. No information about the study, context or results is given.*
FDA Label Image

Figure (Tadalafil Figure4)

Figure (Tadalafil Figure4)
This is a graph displaying the plasma concentration of Tadalafil in micrograms per liter (ug/L) over time in hours. The graph shows the concentration after a single 20-mg dose of Tadalafil, a single 5-mg dose, and a once-daily 5-mg dose for 5 consecutive days. The concentrations range from 500 ug/L down to 100 ug/L. The graph spans a time range of 120 hours.*
FDA Label Image

Figure 5 (Tadalafil Figure5)

Figure 5 (Tadalafil Figure5)
The text describes the change in the IPSS (International Prostate Symptom Score) total score during a treatment with tadalafil compared to a placebo, over a duration of 12 weeks. The graph shows that tadalafil at a certain dosage resulted in a significant improvement in symptoms compared to the placebo, with a p-value <0.01.*
FDA Label Image

Figure 6 (Tadalafil Figure6)

Figure 6 (Tadalafil Figure6)
FDA Label Image

Figure 7 (Tadalafil Figure7)

Figure 7 (Tadalafil Figure7)
FDA Label Image

Figure 8 (Tadalafil Figure8)

Figure 8 (Tadalafil Figure8)
FDA Label Image

Chemical Structure (Tadalafil Structure)

Chemical Structure (Tadalafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.